Mark Christensen, MD
Emergency Medicine · Boaz, ALNPI 1609161124
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $28,375 of the $30,960 with a category attached, or 91.7%. Brainscope Company, Inc. accounts for 97.4% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $14,390 and has fallen 99.5% since, to $72 in 2025. Among emergency medicine clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 33 payments — averaging $938.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Brainscope Company, Inc.$30K
- Mindray DS USA, Inc.$168
- AstraZeneca$130
- Mylan Specialty L.p.$123
- E.r. Squibb & Sons, L.L.C.$116
- Abbott$104
- plus $179 from 8 others
What the payments were for
- Consulting fees$28,37592%
- Travel & lodging$1831%
- Food & beverage$2,4028%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Brainscope Company, Inc. | 8 | $30,141 |
| Mindray DS USA, Inc. | 3 | $168 |
| AstraZeneca | 7 | $130 |
| Mylan Specialty L.p. | 1 | $123 |
| E.r. Squibb & Sons, L.L.C. | 2 | $116 |
| Abbott | 1 | $104 |
| Portola Pharmaceuticals, LLC | 3 | $41 |
| AbbVie | 2 | $39 |
| BTG International Inc. | 1 | $24 |
| Purdue Pharma L.p. | 1 | $18 |
| Biomerieux Inc | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Novo Nordisk | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BrainScope One$30,042
- Yupelri$123
- ACCULINK$104
- ELIQUIS$102
How this compares
$30,960 in reported general payments places this provider in the 95th percentile of 565 emergency medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 123 | $486 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 24 | $346 |
| Ketorolac Tromethamine | 16 | $318 |
| Ondansetron OdtOndansetron | 48 | $276 |
| Cephalexin | 37 | $269 |
| Methylprednisolone | 29 | $257 |
| Ciprofloxacin Hcl | 31 | $205 |
| Methocarbamol | 26 | $172 |
| Clindamycin Hcl | 13 | $166 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $164 |
| Azithromycin | 29 | $161 |
| Prednisone | 37 | $96 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 22 | $79 |
| Omeprazole | 13 | $60 |
| Cyclobenzaprine Hcl | 13 | $46 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Boaz
- Mark MitchellAtmore$309K
- James GalbraithBirmingham$74K
- Lauren WalterBirmingham$64K
- Lisa Moreno-WaltonMobile$23K
- Jeremy TownsPell City$10K
- Malika AryanpureNorthport$9K
- Jorge AlsipMobile$8K
- Brian HassaniMontgomery$4K
- Maxwell ThompsonBirmingham$4K
- Richard BeverlyMobile$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.